Extended Data Fig. 3: Proportion of patients with common CH-PD mutations by primary tumor sites.
From: Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Genes mutated in at least 75 individuals and the top 12 primary tumor sites are shown.
